#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16880	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2598	803.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1729	1729	C	1023	C	1023	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4073	869.2	0	.	n	.	0	T695C	SNP	695	695	T	1334	1334	C	1057	C,T,G	1054,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4073	869.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1976	1976	A	1137	A,C	1135,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4073	869.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2610	2610	C	1005	C,T,A	1000,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4073	869.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2684	2684	A	833	A,C	831,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4073	869.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3236	3236	C	1060	C,A	1059,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28382	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4073	869.2	0	HET	.	.	.	C2403T,A	.	2403	2403	C	3042	3042	C	951	C,T,A	752,196,3	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2370	folP	855	855	100.0	folP.l15.c4.ctg.1	1905	155.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1213	1215	AGC	242;242;239	A;G;C	242;242;239	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5272	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3913	168.0	1	SNP	p	S91F	1	.	.	271	273	TTC	818	820	TTC	192;192;190	T,G;T,G;C	191,1;190,2;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5272	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3913	168.0	1	SNP	p	D95G	1	.	.	283	285	GGC	830	832	GGC	192;193;193	G;G,C;C	192;192,1;193	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5272	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3913	168.0	1	SNP	p	G95N	0	.	.	283	285	GGC	830	832	GGC	192;193;193	G;G,C;C	192;192,1;193	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2086	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1776	146.5	1	SNP	p	G45D	0	.	.	133	135	GGC	711	713	GGC	261;262;261	G,T,A;G;C	259,1,1;262;261	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1162	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1375	105.2	0	.	n	.	0	A197.	DEL	197	197	A	754	754	A	227	A	227	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3601	185.9	1	SNP	p	D86N	0	.	.	256	258	GAC	830	832	GAC	254;253;255	G,T;A,G,C;C,A	253,1;251,1,1;253,2	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3601	185.9	1	SNP	p	R87I	0	.	.	259	261	CGT	833	835	CGT	254;253;253	C;G;T,A	254;253;252,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3601	185.9	1	SNP	p	S87R	1	.	.	259	261	CGT	833	835	CGT	254;253;253	C;G;T,A	254;253;252,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3601	185.9	1	SNP	p	R87W	0	.	.	259	261	CGT	833	835	CGT	254;253;253	C;G;T,A	254;253;252,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3601	185.9	1	SNP	p	S88P	0	.	.	262	264	TCC	836	838	TCC	256;256;258	T;C,T;C	256;255,1;258	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4636	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3021	191.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1767	1769	GGC	254;253;253	G;G;C,A	254;253;252,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1482	1484	GCA	239;239;239	G;C;A,C	239;239;238,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1485	1487	ATC	239;239;240	A;T,G;C	239;238,1;240	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1497	1499	GTG	244;244;245	G;T;G	244;244;245	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1497	1499	GTG	244;244;245	G;T;G	244;244;245	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2001	2003	ACC	245;245;245	A,G;C;C	244,1;245;245	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2055	2057	GCG	241;241;239	G;C;G	241;241;239	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2055	2057	GCG	241;241;239	G;C;G	241;241;239	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2178	2180	AGC	246;246;244	A;G;C	246;246;244	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2187	2189	GGC	248;246;249	G;G;C	248;246;249	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4496	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2967	189.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2205	2207	CCG	248;247;245	C,G;C;G,C	246,2;247;244,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6182	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3601	214.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1905	1907	CCG	252;252;252	C,A;C,A;G	250,2;251,1;252	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2542	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2370	133.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	834	834	C	213	C	213	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	S271T	NONSYN	811	813	TCG	62	64	ACT	88;88;88	A;C;T	88;88;88	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	68	70	GAT	88;88;88	G;A;T	88;88;88	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	71	73	AGT	88;88;88	A;G;T	88;88;88	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	80	82	TAC	88;88;88	T;A;C	88;88;88	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	R307E	NONSYN	919	921	AGA	170	172	GAA	1;1;1	G;A;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	182	184	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	E312D	NONSYN	934	936	GAA	185	187	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	191	193	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	197	199	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	203	205	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	206	208	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	209	211	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	232	90.95	porB1a.l15.c30.ctg.2	418	35.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	215	217	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	576	578	GTT	247;250;251	G,T,A;T;T,G	245,1,1;250;249,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	N121S	NONSYN	361	363	AAC	804	806	AGC	207;208;211	A;G,T;C	207;207,1;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	807	809	AAA	206;206;206	A;A,C;A	206;205,1;206	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	834	836	TAT	216;216;217	T,G;A;T,G	215,1;216;216,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	N134E	NONSYN	400	402	AAT	843	845	GAG	210;210;211	G,A;A,G;G	209,1;209,1;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	V135L	NONSYN	403	405	GTG	846	848	CTT	211;214;215	C;T,G;T,G	211;213,1;214,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	G140K	NONSYN	418	420	GGA	861	863	AAA	214;214;215	A,G;A,C;A,T,C	213,1;213,1;213,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	870	872	GAA	206;206;205	G;A;A	205;206;205	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	894	896	GCA	211;211;211	G;C;A	211;211;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	A196V	NONSYN	586	588	GCC	1029	1031	GTC	297;292;291	G;T,G;C,T	297;291,1;290,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	K207_M208insK	INS	619	619	A	1062	1062	A	297	A	297	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1080	1082	TCA	280;274;272	T,G;C,A;A,C	279,1;273,1;271,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2768	porB1b	1038	1038	96.28	porB1b.l15.c17.ctg.1	1908	179.5	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1197	1197	T	187	T	187	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	276	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	67.8	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	89;89;89	A;C;T	89;89;89	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	276	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	67.8	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	89;89;89	A;G;T	89;89;89	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	276	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	67.8	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	89;89;89	G;A;C	89;89;89	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	276	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	67.8	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	89;89;89	T;A;C	89;89;89	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11120	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5359	259.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1620	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1444	139.7	1	SNP	p	V57M	1	.	.	169	171	ATG	725	727	ATG	289;293;294	A;T;G	289;293;294	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
